People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ocera Therapeutics Inc | — | Biotechnology | Seed | $1.5M | $66.6M | 2012 |
Lars Ekman, M.D., Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lars Ekman, M.D., Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nina Kjellson | 1 | 11 |
| Eckard Weber, M.D. | 1 | 5 |
| Michael Powell, Ph.D. | 1 | 2 |
| Dana McGowan | 1 | 2 |
| Pratik Shah, Ph.D. | 1 | 2 |
| Linda Grais, M.D. | 1 | 1 |
| Joseph Davie, M.D., Ph.D. | 1 | 1 |
| Laurent Fischer, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.